RIGEL PHARMACEUTICALS INC Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2024.
  • Rigel Pharmaceuticals Inc Operating Lease, Payments for the quarter ending September 30, 2024 was $184K, a 3.37% increase year-over-year.
  • Rigel Pharmaceuticals Inc Operating Lease, Payments for the twelve months ending September 30, 2024 was $734K, a 81.6% decline year-over-year.
  • Rigel Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $1.53M, a 85.4% decline from 2022.
  • Rigel Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $10.5M, a 4% increase from 2021.
  • Rigel Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $10.1M, a 4% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $734K $184K +$6K +3.37% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $728K $184K +$6K +3.37% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $722K $184K -$812K -81.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.53M $182K -$2.45M -93.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $3.98M $178K -$2.45M -93.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $6.43M $178K -$2.45M -93.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $8.89M $996K -$1.6M -61.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $10.5M $2.63M +$101K +4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $10.4M $2.63M +$101K +3.99% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $10.3M $2.63M +$101K +3.99% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $10.2M $2.6M +$100K +4.01% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $10.1M $2.53M +$97K +3.99% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $9.99M $2.53M +$98K +4.03% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $9.89M $2.53M +$97K +3.99% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $9.79M $2.5M +$96K +4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $9.69M $2.43M +$94K +4.02% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $9.6M $2.43M +$93K +3.98% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $9.51M $2.43M +$94K +4.02% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $9.41M $2.4M +$92K +3.99% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $9.32M $2.34M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $2.34M Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $2.34M Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $2.31M Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.